# Intravitreal Bevacizumab for Neovascular Glaucoma

> **NCT00384631** · NA · COMPLETED · sponsor: **Shahid Beheshti University of Medical Sciences** · enrollment: 26 (actual)

## Conditions studied

- Neovascular
- Glaucoma

## Interventions

- **OTHER:** subconjunctival normal saline
- **DRUG:** Avastin

## Key facts

- **NCT ID:** NCT00384631
- **Lead sponsor:** Shahid Beheshti University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-04
- **Primary completion:** —
- **Final completion:** 2007-03
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2008-02-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00384631

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00384631, "Intravitreal Bevacizumab for Neovascular Glaucoma". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00384631. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*